| pubmed-article:20209763 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20209763 | lifeskim:mentions | umls-concept:C0022646 | lld:lifeskim |
| pubmed-article:20209763 | lifeskim:mentions | umls-concept:C0033105 | lld:lifeskim |
| pubmed-article:20209763 | lifeskim:mentions | umls-concept:C1306673 | lld:lifeskim |
| pubmed-article:20209763 | lifeskim:mentions | umls-concept:C0035826 | lld:lifeskim |
| pubmed-article:20209763 | lifeskim:mentions | umls-concept:C0205191 | lld:lifeskim |
| pubmed-article:20209763 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:20209763 | pubmed:dateCreated | 2010-3-8 | lld:pubmed |
| pubmed-article:20209763 | pubmed:abstractText | A high prevalence of reduced GFR has been reported in Western populations. However, little is known about the real prevalence of chronic kidney disease (CKD) in Eastern Europe. Our aims were 1) to identify the true burden of CKD in a large adult population sample; 2) to compare the GFR estimates by the "classic" MDRD4 formula with the GFR derived from the formula proposed recently by Levey. | lld:pubmed |
| pubmed-article:20209763 | pubmed:language | rum | lld:pubmed |
| pubmed-article:20209763 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20209763 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20209763 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20209763 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20209763 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20209763 | pubmed:issn | 0048-7848 | lld:pubmed |
| pubmed-article:20209763 | pubmed:author | pubmed-author:SchillerAA | lld:pubmed |
| pubmed-article:20209763 | pubmed:author | pubmed-author:CovicAA | lld:pubmed |
| pubmed-article:20209763 | pubmed:author | pubmed-author:CepoiVV | lld:pubmed |
| pubmed-article:20209763 | pubmed:author | pubmed-author:OlariuNN | lld:pubmed |
| pubmed-article:20209763 | pubmed:author | pubmed-author:Gusbeth-Tatom... | lld:pubmed |
| pubmed-article:20209763 | pubmed:author | pubmed-author:SeicaAncaA | lld:pubmed |
| pubmed-article:20209763 | pubmed:author | pubmed-author:Constantinesc... | lld:pubmed |
| pubmed-article:20209763 | pubmed:author | pubmed-author:Brede?eanVV | lld:pubmed |
| pubmed-article:20209763 | pubmed:author | pubmed-author:Mih?escuAdeli... | lld:pubmed |
| pubmed-article:20209763 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:20209763 | pubmed:volume | 112 | lld:pubmed |
| pubmed-article:20209763 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20209763 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20209763 | pubmed:pagination | 922-31 | lld:pubmed |
| pubmed-article:20209763 | pubmed:dateRevised | 2011-1-13 | lld:pubmed |
| pubmed-article:20209763 | pubmed:meshHeading | pubmed-meshheading:20209763... | lld:pubmed |
| pubmed-article:20209763 | pubmed:meshHeading | pubmed-meshheading:20209763... | lld:pubmed |
| pubmed-article:20209763 | pubmed:meshHeading | pubmed-meshheading:20209763... | lld:pubmed |
| pubmed-article:20209763 | pubmed:meshHeading | pubmed-meshheading:20209763... | lld:pubmed |
| pubmed-article:20209763 | pubmed:meshHeading | pubmed-meshheading:20209763... | lld:pubmed |
| pubmed-article:20209763 | pubmed:meshHeading | pubmed-meshheading:20209763... | lld:pubmed |
| pubmed-article:20209763 | pubmed:meshHeading | pubmed-meshheading:20209763... | lld:pubmed |
| pubmed-article:20209763 | pubmed:meshHeading | pubmed-meshheading:20209763... | lld:pubmed |
| pubmed-article:20209763 | pubmed:meshHeading | pubmed-meshheading:20209763... | lld:pubmed |
| pubmed-article:20209763 | pubmed:meshHeading | pubmed-meshheading:20209763... | lld:pubmed |
| pubmed-article:20209763 | pubmed:meshHeading | pubmed-meshheading:20209763... | lld:pubmed |
| pubmed-article:20209763 | pubmed:meshHeading | pubmed-meshheading:20209763... | lld:pubmed |
| pubmed-article:20209763 | pubmed:meshHeading | pubmed-meshheading:20209763... | lld:pubmed |
| pubmed-article:20209763 | pubmed:meshHeading | pubmed-meshheading:20209763... | lld:pubmed |
| pubmed-article:20209763 | pubmed:meshHeading | pubmed-meshheading:20209763... | lld:pubmed |
| pubmed-article:20209763 | pubmed:meshHeading | pubmed-meshheading:20209763... | lld:pubmed |
| pubmed-article:20209763 | pubmed:meshHeading | pubmed-meshheading:20209763... | lld:pubmed |
| pubmed-article:20209763 | pubmed:meshHeading | pubmed-meshheading:20209763... | lld:pubmed |
| pubmed-article:20209763 | pubmed:articleTitle | [Stage 3-5 chronic kidney disease--what is the real prevalence in Romania?]. | lld:pubmed |
| pubmed-article:20209763 | pubmed:affiliation | Clinica de Nefrologie, Facultatea de Medicin?, Spitalul Clinic Dr.C.I. Parhon, Universitatea de Medicin? si Farmacie Gr.T. Popa Iasi. | lld:pubmed |
| pubmed-article:20209763 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20209763 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:20209763 | pubmed:publicationType | Multicenter Study | lld:pubmed |
